Clinical Trial: A Study on Bioequivalence of Cabergoline Tablets in Human Body

U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008417) titled 'A Study on Bioequivalence of Cabergoline Tablets in Human Body' on May 29.

Brief Summary: The purpose of this study is to evaluate the bioequivalence of the test formulation and reference formulation of cabergoline tablets in healthy Chinese subjects under fasting and postprandial conditions.

Study Start Date: July 08

Study Type: INTERVENTIONAL

Condition: Hyperprolactinemia

Intervention: DRUG: Cabergoline tablets test formulation

Single oral administration

DRUG: Cabergoline tablets reference formulation

Single oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd....